Reports - Digital Therapeutics Market
Biotechnology and Life SciencesDigital Therapeutics Market
Digital Therapeutics Market Size and Projected Growth Through 2035 by Application (Diabetes, Obesity, CVD, CNS Disease), by End-Use (Patients, Providers, Payers, Employers), by Region (North America, Europe, Asia Pacific, Latin America
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Digital Therapeutics Market - Segment Analysis
1. Overview
2. Global Digital Therapeutics Market, 2021 - 2035 (USD Million)
3. Global Digital Therapeutics Market - by Application
3.1. By Diabetes
3.2. By Obesity
3.3. By CVD
3.4. By CNS Disease
3.5. By Respiratory Diseases
3.6. By Smoking Cessation
3.7. By Others
4. Global Digital Therapeutics Market - by End-Use
4.1. By Patients
4.2. By Providers
4.3. By Payers
4.4. By Employers
4.5. By Others
5. Global Digital Therapeutics Market - by region
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Latin America
5.5. Middle East & Africa
6. Market comparative analysis
Chapter 4 North America Digital Therapeutics Market - Segment Analysis
1. Overview
2. North America Digital Therapeutics Market, 2021 - 2035 (USD Million)
3. North America Digital Therapeutics Market - by Application
3.1. By Diabetes
3.2. By Obesity
3.3. By CVD
3.4. By CNS Disease
3.5. By Respiratory Diseases
3.6. By Smoking Cessation
3.7. By Others
4. North America Digital Therapeutics Market - by End-Use
4.1. By Patients
4.2. By Providers
4.3. By Payers
4.4. By Employers
4.5. By Others
Chapter 5 Europe Digital Therapeutics Market - Segment Analysis
1. Overview
2. Europe Digital Therapeutics Market, 2021 - 2035 (USD Million)
3. Europe Digital Therapeutics Market - by Application
3.1. By Diabetes
3.2. By Obesity
3.3. By CVD
3.4. By CNS Disease
3.5. By Respiratory Diseases
3.6. By Smoking Cessation
3.7. By Others
4. Europe Digital Therapeutics Market - by End-Use
4.1. By Patients
4.2. By Providers
4.3. By Payers
4.4. By Employers
4.5. By Others
Chapter 6 Asia Pacific Digital Therapeutics Market - Segment Analysis
1. Overview
2. Asia Pacific Digital Therapeutics Market, 2021 - 2035 (USD Million)
3. Asia Pacific Digital Therapeutics Market - by Application
3.1. By Diabetes
3.2. By Obesity
3.3. By CVD
3.4. By CNS Disease
3.5. By Respiratory Diseases
3.6. By Smoking Cessation
3.7. By Others
4. Asia Pacific Digital Therapeutics Market - by End-Use
4.1. By Patients
4.2. By Providers
4.3. By Payers
4.4. By Employers
4.5. By Others
Chapter 7 Latin America Digital Therapeutics Market - Segment Analysis
1. Overview
2. Latin America Digital Therapeutics Market, 2021 - 2035 (USD Million)
3. Latin America Digital Therapeutics Market - by Application
3.1. By Diabetes
3.2. By Obesity
3.3. By CVD
3.4. By CNS Disease
3.5. By Respiratory Diseases
3.6. By Smoking Cessation
3.7. By Others
4. Latin America Digital Therapeutics Market - by End-Use
4.1. By Patients
4.2. By Providers
4.3. By Payers
4.4. By Employers
4.5. By Others
Chapter 8 Middle East & Africa Digital Therapeutics Market - Segment Analysis
1. Overview
2. Middle East & Africa Digital Therapeutics Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Digital Therapeutics Market - by Application
3.1. By Diabetes
3.2. By Obesity
3.3. By CVD
3.4. By CNS Disease
3.5. By Respiratory Diseases
3.6. By Smoking Cessation
3.7. By Others
4. Middle East & Africa Digital Therapeutics Market - by End-Use
4.1. By Patients
4.2. By Providers
4.3. By Payers
4.4. By Employers
4.5. By Others
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Omada Health Inc. (US)
2. WellDoc Inc. (US)
3. 2Morrow Inc (US).
4. Livongo Health (US)
5. Propeller Health (US)
6. Pear Therapeutics (US)
7. Canary Health Inc. (US)
8. Noom Health Inc. (US)
9. Mango Health Inc. (US)
10. Akili Interactive Labs (South Africa)
11. Better Therapeutics (US)
12. Happify Health (US)
13. Kaia Health (US)
14. Medtronic Plc. (Ireland)
15. Teladoc Health Inc (US)
16. and Fitbit Health Solutions (US).
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By